Glutathione

From Retapedia, the free peptide encyclopedia
Medical disclaimer. This article is for informational purposes only and does not constitute medical advice. Consult a qualified clinician before considering any compound discussed below. See Retapedia : Medical disclaimer.

Glutathione is a therapeutically researched peptide studied for its effects on skin and hair, anti-aging, anti-inflammatory. Endogenous tripeptide antioxidant (glutamate-cysteine-glycine) supporting liver detox, skin brightening, and anti-aging. Permitted under WADA rules.

Glutathione (GSH) is a tripeptide made of the amino acids glutamate, cysteine, and glycine, and is the body's most abundant intracellular antioxidant. It is found in plants, animals, fungi, and some bacteria and archaea, and prevents damage to important cellular components caused by reactive oxygen species, free radicals, peroxides, lipid peroxides, and heavy metals. Beyond direct radical scavenging, glutathione supports phase-II liver detoxification, regenerates other antioxidants such as vitamins C and E, and maintains cellular redox balance.

Natty status
Glutathione is generally regarded as compatible with natural bodybuilding, though competitive federations may differ. See § Natty status.

Overview

Supplemental glutathione — oral (including liposomal), intravenous, intramuscular, or subcutaneous — is used for antioxidant support, liver health, and dermatological skin-brightening protocols, though oral bioavailability of standard formulations is limited.

Glutathione is permitted under World Anti-Doping Agency (WADA) rules as a substance; only high-volume intravenous infusion is restricted as a method, not glutathione itself.

Mechanism of action

The body's master intracellular antioxidant. Scavenges free radicals and supports liver phase-II detoxification. Regenerates vitamins C and E. Used for liver health, skin brightening, and anti-aging.

Reported effects

Effects reported in the literature and from preclinical models include:

  • Acts as a core cellular antioxidant system that, alongside superoxide dismutase and catalase, modulates mitochondrial reactive-oxygen-species signaling and limits radiation-induced oxidative injury. [3] Preclinical
  • Through the SLC7A11-glutathione peroxidase 4 (GPX4) antioxidant axis, glutathione restrains lipid peroxidation and ferroptotic cell death, while its depletion promotes ferroptotic tissue injury. [2][6][7][9] Preclinical
  • Raising intracellular glutathione levels helps neutralize reactive oxygen species and protect cells from apoptosis. [1] Preclinical
  • As a dietary bioactive compound glutathione is associated with anti-inflammatory, antioxidant, and neuroprotective effects with potential anti-aging benefit. [5] Preclinical
  • Falling intestinal glutathione content tracks with elevated malondialdehyde, marking depletion of antioxidant defense under oxidative stress. [4] Preclinical
  • Thalamic glutathione is selectively reduced in migraine patients versus controls with strong diagnostic performance, implicating lower brain antioxidant capacity as a candidate biomarker. [8] Anecdotal

Evidence grades: FDA approved Phase III Phase II Phase I Preclinical Anecdotal

Dosage and administration

Dosage information is included for encyclopedic purposes only. Retapedia does not provide medical advice. See Retapedia : Medical disclaimer.

Oral

  • General: 250-500mg daily, taken on an empty stomach (standard oral bioavailability is low)
  • Liposomal: 500-1000mg daily (enhanced absorption versus standard oral)

Intravenous

  • Antioxidant/skin protocols: 600-1200mg, 1-3 times weekly

Intramuscular

  • 200-600mg, 1-3 times weekly

Subcutaneous

  • 100-300mg, several times weekly

Cofactor support

  • pair with vitamin C and N-acetylcysteine (NAC) to aid synthesis and recycling

Natty status

Glutathione is generally regarded as compatible with the natty designation, particularly when used for therapeutic healing purposes. Opinions vary across natural bodybuilding federations, and athletes who compete should consult the rulebook of their respective sanctioning body.[10]

Research

163 active clinical trials on record — highest phase: Phase 4
View on ClinicalTrials.gov · fetched Jul 17, 2026

The peptide has been the subject of 14 studies and reference works collected on this site. The full bibliography is in § External links below.

Other peptides in this catalogue with overlapping mechanisms or status:

References

  1. ^ Bioactive plant metabolites with antihyperglycemic properties: prospects for the prevention and treatment of diabetes mellitus. Recent review
  2. ^ Endothelial ferroptosis in blood-brain barrier dysfunction and neuroinflammation: mechanisms and immune-vascular crosstalk. Recent review
  3. ^ Targeting mitochondria as a potential therapeutic strategy against radioresistance in cancer. Recent review
  4. ^ Comprehensive analysis of pathogenic mechanisms of Enterobacter cancerogenus ECL9 in silkworms. Recent review
  5. ^ Ostrich Meat: A Review on Nutritional Properties and Health Benefits. Recent review
  6. ^ Ferroptosis, lipid metabolism, and genetic regulation in postoperative rehabilitation of elderly hip fractures: from molecular mechanisms to clinical translation. Recent review
  7. ^ The role of ferroptosis in the pathogenesis and treatment of breast cancer. Recent review
  8. ^ Selective reduction of thalamic glutathione in migraine in the absence of detectable N-acetylaspartate alterations. Recent review
  9. ^ Biogenic selenium nanoparticles: a multifunctional tool for combating oxidative stress and chronic diseases. Recent review
  10. a b World Anti-Doping Agency. (2026). Prohibited List 2026.

External links

This page was last updated on July 17, 2026, at 16:20 (UTC).

Research last reviewed on July 17, 2026.

Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply.